glp-1 obesity market news today Home Delivery Injectables | Global Market Analysis Report GLP-1 Agonists Weight Loss Drugs
Description
Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis by enhancing insulin secretion, suppressing glucagon ...
Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)
Understanding the biological, behavioral, and genetic factors behind this frustration can help you restart progress and achieve your goals
Weight loss can be a challenging journey, especially when it involves managing appetite, metabolism, and lifestyle changes
That seems like the point
Calibrated for GLP-1 users eating smaller volumes.
